Drug Type Microbiota |
Synonyms |
Target- |
Action modulators |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rectal Cancer | Phase 1 | United States | 28 Apr 2023 | |
Sigmoid Neoplasms | Phase 1 | United States | 28 Apr 2023 |
NCT05943041 (SITC2024) Manual | Phase 1 | 9 | (ukwjarrpxo) = none ztmdptqopg (ykhwxnqnli ) View more | Positive | 05 Nov 2024 |